Skip to main content

SAEN · Genenta Science S.p.A.

Track SAEN — free
$0.65 +0.03 (+4.13%) At close · Nov 13
Market Cap
$31.33M
Shares
48.22M
Volume · Nov 13 18.86K Avg daily vol (15 sessions) 185.3K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.65 Open$0.62 Day$0.60–0.67 Available close range$0.61–0.99 Avg vol available · 15d185K Short vol60% DataOct 2026–Nov 2026

The closing range uses available history since Oct 26, 2026; less than a full year is stored.

Latest documents

2026
Nov 2
Current report 6-K
Current report

Genenta Science S.p.A. will operate as Saentra Forge, with its ADSs expected to begin trading under ticker symbol “SAEN” on November 4, 2026, subject to final Nasdaq confirmation. The Board approved both changes on October 20, 2026.

Oct 22
Current report 6-K
Current report

On October 19, 2026, the Tribunal of Milan suspended Genenta Science S.p.A.’s resolution appointing its Board of Directors, causing the prior Board to resume in a prorogatio regime; the company plans to appeal.

Oct 21
Current report 6-K
Current report

Genenta Science S.p.A. received Nasdaq’s minimum bid price deficiency notice after its ADS closing bid remained below $1.00 per ADS for 30 consecutive business days. Nasdaq granted 180 calendar days, until April 14, 2027, to regain compliance.

Oct 13
Current report 6-K
Current report

Genenta Science S.p.A.’s shareholders did not approve the proposed change of its legal name to Saentra Forge S.p.A. on October 8, 2026, so the registered name remains unchanged. The company continues pursuing its strategic transition toward acquiring established industrial businesses.

Oct 7
Current report 6-K
Current report

Genenta Science S.p.A.’s capital increase for its A.T.C. S.r.l. acquisition remains effective after the Court of Milan denied minority shareholders’ interim-suspension application in an order dated October 2, 2026; the merits case remains pending and the order may be appealed.

All documents

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Limited Sentiment Bullish Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 18.7 · elevated Equity put/call 0.72
Technical
price trend
Sell
50 / 200-day cross No cross
RSI (14) 51
neutral
52-week position 12%
near low
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
12 of 9 funds reported for Sep 30 · net +241.6K sh shares · +4 new
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
9 holders — mid 3-yr range
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 220%
annualized · 1-yr
Max drawdown −37%
past year
ATR 16.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
1 · 2 · 0
50 / 200-day cross
No cross Neutral
RSI (14)
51 Neutral
52-week position
12% Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
12 of 9 funds reported for Sep 30 · net +241.6K sh shares · +4 new
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
9 holders — mid 3-yr range
Price context
position in its available closing range
Range low $1 Now $1 · 12% Range high $1

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Conglomerates — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SAEN
Genenta Science S.p.A.
this stock
$31.33M — — — 0.2%
HTHIY
Hitachi Ltd
$137.98B -0.5% — — 0.1%
ITOCF
Itochu Corp
$102.73B +17.7% — — 0.2%
MMM
3M Co
$94.90B +14.7% +1.5% 27.4 1.9%
HON
Honeywell International Inc
$70.60B — +12.9% — 2.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
11
% held
2.0%
Reported
12 of 9
Top holder
Eurizon Capital SGR S.p.A.
Held Float
View
Short & Settlement
Short Volume
Short vol %
60%
As of
Nov 13, 2026
Short Total
View
Financials
Financials
Net income (FY)
EUR -6.5M
EPS diluted
EUR -0.33
View
Filings
SEC Filings
Latest
6-K
Filed
Nov 2, 2026
This year
24

Genenta Science S.p.A. will operate as Saentra Forge, with its ADSs expected to begin trading under ticker symbol “SAEN” on November 4, 2026, subject to final Nasdaq confirmation. The Board approved both changes on October 20, 2026.

View
Earnings & Events
Investor Relations
Latest news
Genenta Unveils Saentra Forge as…
Published
Nov 2, 2026
View

Performance

5D 20D 120D MTD YTD
SAEN -2.3% — — +5.2% —
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY -4.9% — — +5.3% —
Key facts CIK 1838716 13F (30d) 2 filings 2 filers Visit website Investor relations